Literature DB >> 24433686

[Mitomycin C related complications shouldn't be neglected in the pterygium surgery].

Wei-yun Shi1, Fu-hua Wang2.   

Abstract

Mitomycin C (MMC), as it could reduce tissue adhesions and scar formation, has been widely adopted in pterygium surgery to lower the recurrence rate.Upon a certain therapeutic effect obtained, a variety of ocular complications was combined and always occupies a quite long time after MMC application.once occurred, it was tough to cure. Compared to autologous limbal-conjunctival grafts, MMC has no apparent advantage to reduce reoccurrence of pterygium. Therefore, it is advised to abandon the use of MMC in pterygium surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24433686

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  3 in total

Review 1.  Developments and current approaches in the treatment of pterygium.

Authors:  Dilek Hacıoğlu; Hidayet Erdöl
Journal:  Int Ophthalmol       Date:  2016-09-23       Impact factor: 2.031

2.  Conjunctival autograft in pterygium treatment.

Authors:  Sorin Simion Macarie; Daniela Mariana Macarie
Journal:  Rom J Ophthalmol       Date:  2016 Jul-Sep

3.  Iatrogenic Bleb Formation and Hypotony Maculopathy Following Pterygium Surgery with Mitomycin-C.

Authors:  Saeed Shokouhi-Rad; Reza Alizadeh; Ramin Daneshvar
Journal:  J Ophthalmic Vis Res       Date:  2015 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.